◆ Compliance · Essential Oils · 2026
Essential Oil
Labeling & Safety Rules
◆ Short Answer
Selling essential oils in the US: keep claims cosmetic (no "relieves anxiety" or "helps sleep"), use child-resistant packaging when a formula has more than 5% methyl salicylate or is a liquid cosmetic with 10%+ low-viscosity hydrocarbons, follow IFRA limits for skin products, label under MoCRA, and ship many oils as dangerous goods.
By LuxeFormula Labs · October 3, 2026 · 7 min read
The 7 rules that matter
- Claims decide cosmetic vs drug. FDA classifies essential oil products by intended use. "Relieves stress", "helps you sleep", "eases pain", "antiviral" or "boosts immunity" make a product a drug. Scent and ritual language ("a calming lavender scent for your evening") keeps it a cosmetic.
- Child-resistant packaging. Liquids with more than 5% methyl salicylate (wintergreen, sweet birch) and liquid cosmetics with 10% or more low-viscosity hydrocarbons need child-resistant packaging unless an exemption applies, such as spray dispensing (16 CFR 1700.14(a)(3) and (a)(32)). Terpene-rich oils can contain high levels of hydrocarbons, so check each formula.
- Labels. Product identity, net quantity, ingredients in descending order (botanical INCI names), business name and place, and under MoCRA a contact for adverse event reports. Diffuser-only blends should say they are not for skin use.
- Skin use and IFRA. Roll-ons, body oils and butters are leave-on products, so fragrance and essential-oil levels follow IFRA limits for the category — including limits on some phototoxic citrus materials.
- Shipping. Many essential oils are flammable liquids for transport and ship as dangerous goods. Your SDS gives the transport classification; marketplaces such as Amazon review these listings.
- Purity wording. "Therapeutic grade" and similar terms have no regulatory definition. Back "pure" or "single-origin" claims with documents such as CoA or GC-MS results.
- EU allergens. In the EU, fragrance allergens above set thresholds must be named on the label; Regulation (EU) 2023/1545 expands the list, applying to new products from 31 July 2026 and to all products from 31 July 2028.
Cosmetic or drug? Claim examples
| Claim | Category |
|---|---|
| “A calming lavender scent for your evening ritual” | Cosmetic |
| “Fresh peppermint aroma” | Cosmetic |
| “Relieves anxiety” · “Helps you sleep” | Drug |
| “Eases muscle pain” · “Relieves headaches” | Drug |
| “Antibacterial” · “Antiviral” · “Boosts immunity” | Drug |
| “Therapeutic grade” | Undefined — avoid |
Plan your dilution
For roll-ons, body oils and butters, plan drops and milliliters with our free essential oil dilution calculator. Final levels for skin products are set within IFRA limits.
Launching essential oils or blends? We make private label singles, blends, roll-ons and diffuser blends from 100 units per SKU, and check packaging, claims and shipping. Private label essential oils → · Test samples first →
FAQ
Essential Oil
Questions
Some do. Liquids with more than 5% methyl salicylate and liquid cosmetics with 10% or more low-viscosity hydrocarbons need child-resistant packaging unless an exemption applies (16 CFR 1700.14). Check each formula with your supplier.
Not if you sell it as a cosmetic. The FDA lists claims to help you sleep, relieve anxiety or ease pain as drug claims.
No. It has no regulatory definition. Use verifiable facts such as botanical name, origin and test data.
Many are flammable liquids for transport and must ship as dangerous goods. Check the SDS for the transport classification.
For leave-on skin products, fragrance and essential-oil levels should follow IFRA limits for the category, and your supplier can provide an IFRA certificate.
Cosmetic essential oil products fall under MoCRA: facility registration and product listing unless the small-business exemption applies, plus labeling and adverse event reporting.
Sources
- FDA — Aromatherapy (when essential oil products are cosmetics or drugs)
- 16 CFR 1700.14 — Substances requiring child-resistant packaging (methyl salicylate, low-viscosity hydrocarbons)
- FDA — Is it a cosmetic, a drug, or both?
- IFRA — End of consultation for the 52nd Amendment to the IFRA Standards
- FDA — Modernization of Cosmetics Regulation Act (MoCRA)
- Regulation (EU) 2023/1545 — fragrance allergen labelling
General information, not legal advice.
Oils & Butters Resource Center
Everything for Your
Body & Face Care Launch
Oils & buttersAll formats and ready-to-brand conceptsPrivate label face oilLightweight, soft-glow, from 100 unitsPrivate label body oilDry, shimmer and bath oilsPrivate label body butterWhipped, shimmer, scentedPrivate label essential oilsSingles, blends, roll-onsOil & Butter Blind Test BoxB2B samples from $159Essential oil dilution calculatorDrops and ml for any %Private label lip oilVanilla bean · sweet almond concept